| MAY, 2012 Gene-Related Patents Issued - Full patent | ||||
| CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,173,381 | Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer | Agensys, Inc. | 8-May-12 | United States |
| 8,187,850 | Method for producing an L-amino acid using a bacterium of the enterobacteriaceae family with attenuated expression of the ybiV gene | Ajinomoto Co., Inc. | 29-May-12 | Japan |
| 8,187,842 | Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals | Archer Daniels Midland Company | 29-May-12 | United States |
| 8,168,391 | Method for modulating insulin production | Burnham Institute for Medical Research | 1-May-12 | United States |
| 8,187,816 | Probe set, probe-immoblized carrier, and genetic testing method for detecting Anaerococcus prevotii | Canon Kabushiki Kaisha | 29-May-12 | Japan |
| 8,187,803 | Probe, probe set, probe-immobilized carrier, and genetic testing method | Canon Kabushiki Kaisha | 29-May-12 | Japan |
| 8,168,383 | Gene defects and mutant ALK kinase in human solid tumors | Cell Signaling Technology, Inc. | 1-May-12 | United States |
| 8,183,005 | Pharmaceutical agents for treating HCV infections | Chugai Seiyaku Kabushiki Kaisha | 22-May-12 | Japan |
| 8,168,422 | Microorganism producing inosine and method of producing inosine using the same | CJ Cheiljedang Corporation | 1-May-12 | Korea |
| 8,187,840 | Microorganism producing inosine and method of producing inosine using the same | CJ Cheiljedang Corporation | 29-May-12 | Korea |
| 8,168,392 | Tetrahydrofolate synthetase gene | Daiichi Sankyo Co., Ltd. | 1-May-12 | Japan |
| 8,173,387 | Method of examining chemical using gene-disrupted strain | Daikin Industires, Ltd. | 8-May-12 | Japan |
| 8,178,343 | Gene cluster diagnosis apparatus | Fooyin University Hospital | 15-May-12 | Tiwan |
| 8,183,006 | Screening method for identifying new aminoacyl-tRNA synthetase inhibitors | Fundacio Privada Parc Cientific de Barcelona | 22-May-12 | Spain |
| 8,187,805 | Method of detecting nucleic acid and utilization thereof | FUSO Pharmaceutical Industries, Ltd. | 29-May-12 | Japan |
| 8,168,384 | Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy | Guy's and St. Thomas' NHS Foundation Trust | 1-May-12 | United Kingdom |
| 8,187,870 | Means for obtaining avirulent leishmania promastigotes, promastigotes obtained, and the applications thereof | Institut de Recherche pour le Developpement (IRD) | 29-May-12 | France |
| 8,173,429 | Characterization of the I-Spomi endonuclease from fission yeast | Institut Pasteur | 8-May-12 | France |
| 8,183,016 | Synthesis method of aromatic amino acids | I-Shou University | 22-May-12 | Tiwan |
| 8,187,841 | Method for evaluating or selecting agent for preventing or curing photodamage of skin | Kao Corporation | 29-May-12 | Japan |
| 8,178,320 | Artificial antibody library with super-repertory | Keio University | 15-May-12 | Japan |
| 8,187,858 | Hansenula polymorpha gene coding for dolichyl-phosphate-mannose dependent alpha-1,3-mannosyltransferase and process for the production of recombinant glycoproteins with Hansenula polymorpha mutant strain deficient in the same gene | Korea Research Institute of Bioscience and Biotechnology | 29-May-12 | Korea |
| 8,187,826 | Quantitative analysis of in vivo mutation at the Pig-A locus | Litron Laboratories, Ltd. | 29-May-12 | United States |
| 8,178,293 | Uses of BNIPXL-beta in premature canities | L'Oreal | 15-May-12 | France |
| 8,178,348 | Chimeric antisense oligonucleotides of arabinofuranose analogue and deoxyribose nucleotides | McGill University | 15-May-12 | Canada |
| 8,183,026 | Methods of preparation of live attenuated bacterial vaccine by alteration of DNA adenine methylase (Dam) activity in those bacteria | Mississippi State University | 22-May-12 | United States |
| 8,168,395 | Taste receptors of the T1R family from domestic dog | Monell Chemical Senses Center | 1-May-12 | United States |
| 8,178,291 | Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors | Monogram Biosciences, Inc. | 15-May-12 | United States |
| 8,168,426 | Multiple inducible gene regulation system | ntrexon Corporation | 1-May-12 | United States |
| 8,182,997 | Prostate cancer related gene STYK1 | Oncotherapy Science, Inc. | 22-May-12 | Japan |
| 8,168,407 | Method of synthesizing a suppressor TRNA, DNA construct and use thereof for producing a protein including a non-natural amino acid | Riken | 1-May-12 | Japan |
| 8,187,860 | Recombinant microalgae cells producing novel oils | Solazyme, Inc. | 29-May-12 | United States |
| 8,168,425 | Expression of factor IX in gene therapy vectors | St. Jude Children's Research Hospital | 1-May-12 | United States |
| 8,178,299 | Method to determine the risk for side effects of an SSRI treatment in a person | The Board of Trustees of the Leland Stanford Junior University | 15-May-12 | United States |
| 8,178,338 | Inducible expression vectors and methods of use thereof | The Regents of the University of California | 15-May-12 | United States |
| 8,178,298 | Patched polypeptides and uses related thereto | The Regents of the University of California | 15-May-12 | United States |
| 8,187,859 | Modulating urea degradation in wine yeast | The University of British Columbia | 29-May-12 | Canada |
| 8,182,987 | Probe for visualizing cell-cycle | Tokyo Metropolitan Institute of Medical Science | 22-May-12 | Japan |
| 8,168,390 | Method and apparatus for diagnosing age-related macular degeneration | University of Regensburg | 1-May-12 | Germany |
| 8,173,423 | Diagnosis and treatment of T-cell acute lymphoblastic leukemia | VIB VZW | 8-May-12 | Belgium |
| DATA PROCESSING | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,170,808 | Methods and computer software for detecting splice variants | Affymetrix, Inc. | 1-May-12 | United States |
| 8,185,367 | Systems and methods for reconstructing gene networks in segregating populations | Merck Sharp & Dohme Corp. | 22-May-12 | United States |
| 8,170,805 | Method for selecting statistically validated candidate genes | Syngenta Participations AG | 1-May-12 | Switzerland |
| 8,170,852 | Data structures and methods for modeling Saccharomyces cerevisiae metabolism | The Regents of the University of California | 1-May-12 | United States |
| DRUG | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,168,187 | Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer | Agensys, Inc. | 1-May-12 | United States |
| 8,173,132 | Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer | Agensys, Inc. | 8-May-12 | United States |
| 8,173,607 | Promoter for the production of hyaluronic acid containing ginsenoside compound K | Amorepacific Corporation | 8-May-12 | Korea |
| 8,187,606 | HPV antigen fusion protein vaccine compositions and uses thereof | Beijing Sunbio Biotech Co., Ltd. | 29-May-12 | China P. Rep. |
| 8,178,111 | GM-negative EHV-mutants without heterologous elements | Boehringer Ingelheim Vetmedica GmbH | 15-May-12 | Germany |
| 8,183,217 | Methods and means for obtaining modified phenotypes | Commonwealth Scientific and Industrial Research Organisation | 22-May-12 | Australia |
| 8,168,178 | Methods and compositions for regulating lymphocyte activity | Curis, Inc. | 1-May-12 | United States |
| 8,183,223 | Method for detecting carcinoma and agent for suppressing carcinoma | Fujifilm Corporation | 22-May-12 | Japan |
| 8,168,587 | Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases | Genezyme Corporation | 1-May-12 | United States |
| 8,183,220 | Double-effective vaccine vector against foot-and-mouth disease virus (FMDV), methods of preparing and using the same | Lanzhou Veterinary Research Institute Chinese Academy of Agricultural Sciences | 22-May-12 | China P. Rep. |
| 8,188,131 | Compounds that enhance Atoh1 expression | Massachusetts Eye & Ear Infirmary | 29-May-12 | United States |
| 8,173,614 | Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof | Medtronic, Inc. | 8-May-12 | United States |
| 8,173,612 | Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis | Nath; Rahul K. | 8-May-12 | United States |
| 8,188,032 | G-CSF transferrin fusion proteins | National Institutes of Health (NIH) | 29-May-12 | United States |
| 8,168,607 | Methods of treating eye diseases in diabetic patients | Quark Pharmaceuticals Inc. | 1-May-12 | United States |
| 8,168,166 | Live genetically attenuated malaria vaccine | Seattle Biomedical Research Institute | 1-May-12 | United States |
| 8,173,602 | Detecting CYP24 expression level as a marker for predisposition to cancer | The Regents of the University of California | 8-May-12 | United States |
| 8,168,610 | Bispecific oligonucleotide for the treatment of CNS malignancies | The University of British Columbia | 1-May-12 | Canada |
| 8,178,110 | Reovirus compositions and methods of use | University of Georgia Research Foundation, Inc. | 15-May-12 | United States |
| 8,178,504 | Gene therapy expression of GHRH for increasing RBC count in subjects | VGX Pharmaceuticals, Inc. | 15-May-12 | United States |
| 8,188,064 | Vitamin D analogs for obesity prevention and treatment | Wisconsin Alumni Research Foundation | 29-May-12 | United States |
| IMAGE ANALYSIS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,189,898 | Gene expression image constructing method and gene expression image constructing system | Riken | 29-May-12 | Japan |
| MULTICELLULAR LIVING ORGANISMS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,173,865 | Plant having increased yield of seeds | Japan Science and Technology Agency | 8-May-12 | Japan |
| 8,183,432 | Plant having reduced lignin and cellulose contents without reducing glucan content, method of producing the same and utilization thereof | Japan Science and Technology Agency | 22-May-12 | Japan |
| 8,173,859 | Epilepsy model animal | Japan Science and Technology Agency | 8-May-12 | Japan |
| 8,183,435 | Pasture, forage and seed production technology through pod and leaf retention on annuals of the Medicago genus (annual medics) | Pristine Forage Technologies Pty Ltd | 22-May-12 | Australia |
| 8,168,860 | Compositions and methods for the modification of physiological responses in plants | Rohm and Haas Company | 1-May-12 | United States |
| 8,183,434 | Method for producing transgenic surface layer chimeric plant | Suntory Holdings Limited | 22-May-12 | Japan |
| NATURAL RESINS OR DERIVATIVES | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,188,228 | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer | Agensys, Inc. | 29-May-12 | United States |
| 8,173,778 | Antibody to a guanine nucleotide exchange factor | Daiichi Sankyo Company, Limited | 8-May-12 | Japan |
| 8,173,771 | Humanin receptor or humanin-like polypeptide receptor | Keio Univeristy | 8-May-12 | Japan |
| 8,173,769 | Taste receptors of the T1R family from domestic cat | Monell Chemical Senses Center | 8-May-12 | United States |
| 8,178,505 | Method of predicting and reducing risk of metastasis of breast cancer to lung | Sloan-Kettering Institute for Cancer Research | 15-May-12 | United States |
| 8,173,780 | Peptide having ability to activate cancer-related gene | Umezu; Yasuiki | 8-May-12 | Japan |
| ORGANIC COMPOUNDS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,168,775 | Compositions and methods for inhibiting expression of transthyretin | Alnylam Pharmaceuticals, Inc. | 1-May-12 | United States |
| 8,183,362 | Method and medicament for inhibiting the expression of a given gene | Alnylam Pharmaceuticals, Inc. | 22-May-12 | United States |
| 8,168,776 | Method for making a 21 nucleotide double stranded RNA chemically linked at one end | Alnylam Pharmaceuticals, Inc. | 1-May-12 | United States |
| 8,188,249 | Nucleic acid molecules encoding antibodies to M-CSF | Amgen Fremont Inc. | 29-May-12 | United States |
| 8,188,250 | Butanol dehydrogenase enzyme from the bacterium Achromobacter xylosoxidans | Butamax(TM) Advanced Biofuels LLC | 29-May-12 | Germany |
| 8,168,774 | Control of gene expression | Commonwealth Scientific and Industrial Research Organisation | 1-May-12 | Australia |
| 8,183,360 | Population scale HLA-typing and uses thereof | Genomics USA, Inc | 22-May-12 | United States |
| 8,188,244 | Carcinoembryonic antigen fusions and uses thereof | Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA | 29-May-12 | Italy |
| 8,183,219 | Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof | Medtronic, Inc. | 22-May-12 | United States |
| 8,178,661 | Molecules of the card-related protein family and uses thereof | Millennium Pharmaceuticals, Inc. | 15-May-12 | United States |
| 8,173,790 | Insect desiccation resistance genes and uses thereof | National Institute of Agrobiological Sciences | 8-May-12 | Japan |
| 8,188,253 | Penaeidin gene promoters in tiger shrimp and applications thereof | National Taiwan University | 29-May-12 | Tiwan |
| 8,188,265 | Method for the isolation of mRNA from formalin fixed, paraffin-embedded tissue | Pangaea Biotech, S.A. | 29-May-12 | Spain |
| 8,188,263 | Modified siRNA molecules and uses thereof | Protiva Biotherapeutics, Inc. | 29-May-12 | Canada |
| 8,188,264 | RNAi mediated knockdown of NuMA for cancer therapy | Reliance Life Sciences Pvt. Ltd. | 29-May-12 | India |
| 8,188,245 | Enduracidin biosynthetic gene cluster from streptomyces fungicidicus | State of Oregon acting by and through the State Board of Higher Education on behalf of Oregon State University | 29-May-12 | United States |
| 8,173,793 | Nucleic acids encoding modulators of body weight | The Rockefeller University | 8-May-12 | United States |
| 8,183,358 | Puumala virus full-length M segment-based DNA vaccines | The United States of America, as represented by the Secretary of the Army | 22-May-12 | United States |
| 8,173,789 | Peptide having ability to activate cancer-related gene | Umezu; Yasuiki | 8-May-12 | Japan |
| 8,173,788 | Peptide having ability to activate cancer-related gene | Umezu; Yasuiki | 8-May-12 | Japan |
| 8,183,353 | Breast cancer prognostics | Veridex, LLC. | 22-May-12 | United States |
| 8,188,256 | Primer and probe for detection of Mycobacterium intracellulare | Wako Pure Chemical Industries, Ltd. | 29-May-12 | Japan |
| 8,188,262 | Short interference ribonucleic acids for treating allergic diseases | Wholesome Biopharm Pty Ltd | 29-May-12 | Australia |
| SURGERY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,177,775 | Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique | Antisense Pharma GmbH | 15-May-12 | Germany |
| 8,175,711 | Methods for treating a condition or disease associated with cardio-renal function | Ardian, Inc. | 8-May-12 | United States |
Login
To traslate this page, click a flag!
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
